{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:19:39Z","timestamp":1792552779877,"version":"4.5.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The dual triggering combines human chorionic gonadotropin (hCG) with GnRH agonists (aGnRH) to induce the final oocyte maturation in <jats:italic>in vitro<\/jats:italic> fertilization (IVF). When both drugs are used sequentially, it is called \u201cdouble trigger\u201d, but this strategy is rarely used clinically. This review explores the rationale for using dual triggering and compares its reproductive outcome with conventional hCG triggering. Variability in protocols, inclusion criteria, study aims, and weak study designs complicate the evaluation of its clinical benefit. Patients with low response or cycles with high proportion of immature oocytes (&amp;gt;25%) may benefit from dual triggering. In contrast, patients with normal or hyper responsiveness show no significant differences compared to conventional hCG triggering. Further robust studies are needed to clarify the clinical applications of dual triggering. Until then, this strategy should remain part of research protocols rather than routine clinical practice.<\/jats:p>","DOI":"10.3389\/fendo.2025.1556732","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:12:01Z","timestamp":1747908721000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Dual triggering for final oocyte maturation. A narrative review"],"prefix":"10.3389","volume":"16","author":[{"given":"Adriana","family":"Riob\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mart\u00ednez Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Martinez-Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Taboas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"L\u00f3pez de Uralde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elkin","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2010.06.031","article-title":"LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango","volume":"21","author":"Kol","year":"2010","journal-title":"Reprod BioMed Online"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gah198","article-title":"Human FSH beta subunit gene is highly conserved","volume":"11","author":"Lamminen","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"B3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1210\/er.2009-0012","article-title":"The mammalian ovary from genesis to revelation","volume":"30","author":"Edson","year":"2009","journal-title":"Endocr Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-53-1-128","article-title":"Androgens and progestins in the human ovarian follicle: differences in the evolution of preovulatory, healthy nonovulatory, and atretic follicles","volume":"53","author":"Brailly","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/138920112799361945","article-title":"The role of LH in ovarian stimulation","volume":"13","author":"Munoz","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1210\/edrv.18.1.0290","article-title":"Manipulation of human ovarian function: physiological concepts and clinical consequences","volume":"18","author":"Fauser","year":"1997","journal-title":"Endocr Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/humupd\/dmae027","article-title":"New insights into the ovulatory process in the human ovary","volume":"31","author":"Jo","year":"2025","journal-title":"Hum Reprod Update"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/580171","article-title":"Pharmaceutical options for triggering of final oocyte maturation in ART","volume":"2014","author":"Castillo","year":"2014","journal-title":"BioMed Res Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.02.037","article-title":"Oocyte maturation failure: a syndrome of bad eggs","volume":"94","author":"Beall","year":"2010","journal-title":"Fertil Steril"},{"key":"B10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1210\/er.2017-00236","article-title":"Novel concepts for inducing final oocyte maturation in in vitro fertilization treatment","volume":"39","author":"Abbara","year":"2018","journal-title":"Endocr Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a136151","article-title":"Endocrinology: Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys","volume":"10","author":"Zelinski-Wooten","year":"1995","journal-title":"Hum Reprod"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12440","article-title":"Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin-releasing hormone agonist for women undergoing fertility preservation","volume":"21","author":"Hong","year":"2022","journal-title":"Reprod Med Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2022.2101635","article-title":"Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin improves live birth rates in POSEIDON group 3 and 4 expected poor responders","volume":"38","author":"Tulek","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2021.1945560","article-title":"Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves in vitro fertilisation outcomes in poor ovarian responders","volume":"42","author":"Mutlu","year":"2021","journal-title":"J Obst Gynaecol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2021.2000962","article-title":"Effect of dual trigger on reproductive outcome in low responders: a systematic PRISMA review and meta-analysis","volume":"38","author":"Sloth","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1254982","article-title":"Dual trigger for final oocyte maturation in expected normal responders with a high immature oocyte rate: a randomized controlled trial","volume":"10","author":"Yan","year":"2023","journal-title":"Front Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.75.2.1639951","article-title":"Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles","volume":"75","author":"Zelinski-Wooten","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/humupd\/dml062","article-title":"Molecular mechanisms of ovulation: co-ordination through the cumulus complex","volume":"3","author":"Russell","year":"2007","journal-title":"Hum Reprod Update"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00464","article-title":"Immature oocyte for fertility preservation","volume":"10","author":"Son","year":"2019","journal-title":"Front Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmx040","article-title":"Acquisition of oocyte competence to develop as an embryo: integrated nuclear and cytoplasmic events","volume":"24","author":"Conti","year":"2018","journal-title":"Hum Reprod Update"},{"key":"B22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/JU.0000000000001520","article-title":"Diagnosis and treatment of infertility in men: AUA\/ASRM guideline PART II","volume":"205","author":"Schlegel","year":"2021","journal-title":"J Urol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"key":"B24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0015-0282(01)01851-9","article-title":"Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (OvidrelR) to urinary hCG (ProfasiR) for induction of final follicular maturation in in vitro fertilization\u2013embryo transfer","volume":"76","author":"Chang","year":"2001","journal-title":"Fertil Steril"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102037","article-title":"hCG: biological functions and clinical applications","volume":"18","author":"Nwabuobi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B26","unstructured":"Ovitrelle\n          \n          \n          \n          2018"},{"key":"B27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/0300-1652.107549","article-title":"Hormones in pregnancy","volume":"53","author":"Magon","year":"2012","journal-title":"Niger Med J"},{"key":"B28","first-page":"117","article-title":"Ovarian follicular and luteal physiology","volume":"22","author":"Channing","year":"1980","journal-title":"Int Rev Physiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13048-015-0187-6","article-title":"Triggering final follicular maturation- hCG, GnRH-agonist or both, when and to whom","volume":"8","author":"Orvieto","year":"2015","journal-title":"J Ovarian Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(89)90485-8","article-title":"Metabolic fate of human horiogonadotropin","volume":"33","author":"Nisula","year":"1989","journal-title":"J Steroid Biochem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.85575","article-title":"Gonadotropin releasing hormone agonists: Expanding vistas","volume":"15","author":"Magon","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115965","article-title":"Gonadotropin-releasing hormone receptor (GnRHR) and hypogonadotropic hypogonadism","volume":"24","author":"Fanis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"B34","article-title":"Monthly administration of the LH-RH analogue decapeptyl for long-term treatment of ovarian dysfunctions and estrogen-dependent disorders","volume":"34","author":"Geisthoevel","year":"1989","journal-title":"Int J Fertil"},{"key":"B35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/0974-1208.142476","article-title":"Gonadotropin-releasing hormone analogs: Understanding advantages and limitations","volume":"7","author":"Kumar","year":"2014","journal-title":"J Hum Reprod Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction: a Cochrane review","volume":"17","author":"Al-Inany","year":"2002","journal-title":"Hum Reprod"},{"key":"B37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: A 12-month study","volume":"91","author":"Hornstein","year":"1998","journal-title":"Obstet Gynecol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Sterility"},{"key":"B40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ijgo.13405","article-title":"Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: A randomized controlled study","volume":"152","author":"Maged","year":"2020","journal-title":"Int J Gynecol Obstet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235707","article-title":"Dual-trigger improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve: A retrospective cohort study","volume":"15","author":"Chern","year":"2020","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12958-018-0451-x","article-title":"Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve","volume":"17","author":"Lin","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2020.03657","article-title":"Effect of a dual trigger on oocyte maturation in young women with decreased ovarian reserve for the purpose of elective oocyte cryopreservation","volume":"47","author":"Kim","year":"2020","journal-title":"Clin Exp Reprod Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20190056","article-title":"Immature oocyte incidence: Contributing factors and effects on mature sibling oocytes in intracytoplasmic sperm injection cycles","volume":"24","author":"Braga","year":"2020","journal-title":"JBRA Assist Reprod"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2019.1674791","article-title":"Does \u2018Dual trigger\u2019 Increase oocyte maturation rate","volume":"40","author":"Ben-Haroush","year":"2020","journal-title":"J Obstet Gynaecol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.04.028","article-title":"Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates","volume":"102","author":"Griffin","year":"2014","journal-title":"Fertil Steril"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.gofs.2019.06.012","article-title":"Int\u00e9r\u00eat du double d\u00e9clenchement par agoniste de la GnRH et hCG en cas d\u2019ant\u00e9c\u00e9dent d\u2019immaturit\u00e9 ovocytaire en FIV\/ICSI [Dual trigger with gonadotropin-releasing hormone agonist and hCG to improve oocyte maturation rate","volume":"47","author":"Herbemont","year":"2019","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1177\/1933719116682873","article-title":"Dual triggering with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin in patients with a high immature oocyte rate","volume":"24","author":"Fabris","year":"2017","journal-title":"Reprod Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-023-02888-8","article-title":"Dual trigger improves the pregnancy rate in fresh in vitro fertilization (IVF) cycles compared with the human chorionic gonadotropin (hCG) trigger: a systematic review and meta-analysis of randomized trials","volume":"40","author":"Hsia","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.rbmo.2017.06.015","article-title":"The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators","volume":"35","year":"2017","journal-title":"Reprod BioMed Online"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-200306000-00001","article-title":"Failed fertilization: is it predictable","volume":"15","author":"Mahutte","year":"2003","journal-title":"Curr Opi Obstet Gynecol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead093.605","article-title":"P-247 Total Fertilization Failure after conventional IVF: it is not the end of the story","author":"Tondo","year":"2023","journal-title":"Hum Reprod"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2016.08.009","article-title":"Adjuvant gonadotrophin-releasing hormone agonist trigger with human chorionic gonadotrophin to enhance ooplasmic maturity","volume":"33","author":"Pereira","year":"2016","journal-title":"Reprod BioMed Online"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-017-0917-3","article-title":"Combined GnRH-agonist and human chorionic gonadotropin trigger improves ICSI cycle outcomes in patients with history of poor fertilization","volume":"34","author":"Elias","year":"2017","journal-title":"J Assist Reprod Genet"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa107","article-title":"GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study","volume":"35","author":"Haas","year":"2020","journal-title":"Hum Reprod"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.29252\/ijrm.15.7.429","article-title":"Final follicular maturation by administration of GnRH agonist plus HCG versus HCG in normal responders in ART cycles: An RCT","volume":"15","author":"Eftekhar","year":"2017","journal-title":"Int Int J Reprod Biomed"},{"key":"B57","article-title":"Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial","volume":"6","author":"Decleer","year":"2014","journal-title":"Facts views Vis ObGyn"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.183506","article-title":"Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study","volume":"9","author":"Mahajan","year":"2016","journal-title":"J Hum Reprod Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2020.03804","article-title":"Dual trigger in normally-responding assisted reproductive technology patients increases the number of top-quality embryos","volume":"47","author":"\u015e\u00fck\u00fcr","year":"2020","journal-title":"Clin Exp Reprod Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12457","article-title":"Comparison of dual trigger with combination GnRH agonist and hCG versus hCG alone trigger of oocyte maturation for normal ovarian responders","volume":"141","author":"Zhou","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.07.1976","article-title":"Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles","author":"Lin","year":"2013","journal-title":"Fertil Steril"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.683210","article-title":"Effect of a \u2018Dual trigger\u2019 Using a GnRH agonist and hCG on the cumulative live-birth rate for normal responders in GnRH-antagonist cycles","volume":"8","author":"Gao","year":"2021","journal-title":"Front Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12884-022-04899-2","article-title":"Reproductive outcomes of dual trigger with combination GnRH agonist and hCG versus trigger with hCG alone in women undergoing IVF\/ICSI cycles: a retrospective cohort study with propensity score matching","volume":"22","author":"Dong","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20160047","article-title":"Final oocyte maturation in assisted reproduction with human chorionic gonadotropin and gonadotropin-releasing hormone agonist (Dual trigger)","volume":"20","author":"Oliveira","year":"2016","journal-title":"JBRA Assist Reprod"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-016-0755-8","article-title":"GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone","volume":"33","author":"O\u2019Neill","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.03.015","article-title":"Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders","volume":"97","author":"Griffin","year":"2012","journal-title":"Fertil Steril"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23916","article-title":"Dual trigger of triptorelin and hCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-011-9704-8","article-title":"Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS","volume":"29","author":"Castillo","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2017.09.004","article-title":"Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis","volume":"218","author":"Ding","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20220035","article-title":"Dual trigger vs. Conventional trigger outcomes in In Vitro Fertilization. Systematic review and meta-analysis","volume":"27","author":"Gonz\u00e1lez","year":"2023","journal-title":"JBRA Assist Reprod"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100406r","article-title":"Outcomes comparison of IVF\/ICSI among different trigger methods for final oocyte maturation: A systematic review and meta-analysis","volume":"35","author":"Zhang","year":"2021","journal-title":"FASEB J"},{"key":"B72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejogrb.2023.08.014","article-title":"Triggering of ovulation for GnRH-antagonist cycles in normal and low ovarian responders undergoing IVF\/ICSI: A systematic review and meta-analysis of randomized trials","volume":"289","author":"He","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12958-024-01211-z","article-title":"Reproductive outcomes of dual trigger therapy with GnRH agonist and hCG versus hCG trigger in women with diminished ovarian reserve: a retrospective study","volume":"22","author":"Chen","year":"2024","journal-title":"Reprod Biol Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deac114","article-title":"Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF\/ICSI cycles","volume":"37","author":"Zhou","year":"2022","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1556732\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:12:03Z","timestamp":1747908723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1556732\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":74,"alternative-id":["10.3389\/fendo.2025.1556732"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1556732","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"article-number":"1556732"}}